论文部分内容阅读
目的分析稳心颗粒联合美托洛尔治疗冠心病合并室性心律失常的疗效及安全性。方法选取2015年2月~2016年2月本院收治的冠心病合并室性心律失常患者64例,随机将其分为实验组与对照组,各32例。对照组在常规治疗的基础上使用稳心颗粒治疗,实验组患者则在对照组的基础上增加美托洛尔,即稳心颗粒与美托洛尔联合治疗,观察对比两组患者治疗之后的疗效与心电图结果。结果对比两组的疗效,实验组治疗的总有效率为96.88%,明显高于对照组的75%,差异有统计学意义(P<0.05)。比较二者的心电图结果,实验组患者的结果为96.88%,显著优于对照组的78.13%,差异有统计学意义(P<0.05)。结论稳心颗粒与美托洛尔联合应用于冠心病合并室性心律失常治疗,疗效显著,且安全性高,值得临床广泛应用。
Objective To analyze the efficacy and safety of Wenxin granule combined with metoprolol in the treatment of coronary heart disease complicated with ventricular arrhythmia. Methods Sixty-four patients with coronary heart disease and ventricular arrhythmia admitted from February 2015 to February 2016 were randomly divided into experimental group and control group, with 32 cases in each group. The control group was treated with Wenxin Granule on the basis of routine treatment. The patients in the experimental group were given metoprolol on the basis of the control group, that is, the combination of Wenxin Granule and Metoprolol. The difference between the two groups after treatment Efficacy and ECG results. Results Compared with the two groups, the total effective rate of the experimental group was 96.88%, which was significantly higher than that of the control group (75%), the difference was statistically significant (P <0.05). Comparing the results of the two electrocardiograms, the result of the experimental group was 96.88%, which was significantly better than 78.13% of the control group, the difference was statistically significant (P <0.05). Conclusion Wenxin granules combined with metoprolol in the treatment of coronary heart disease complicated with ventricular arrhythmia, the curative effect is obvious, and the safety is high, so it is worth widely clinical application.